Lundbeck | search
Click here to view Lundbeck news from 60+ newspapers.
Bookmark or Share- Careers - LundbeckEqual Opportunity Employer. Lundbeck is proud to be an equal opportunity workplace and an affirmative action employer. We are committed to equal employment opportunity regardless of race, color, religion, sex, sexual orientation, gender identity, age, national origin, disability, protected veteran status, and any other characteristic protected ...
- About Us - LundbeckAbout Us. Lundbeck is a Global Pharmaceutical Company Specialized in Brain Diseases. We are tirelessly dedicated to restoring brain health, so every person can be their best. To fulfill this purpose, Lundbeck is engaged in the research, development, manufacturing, and commercialization of pharmaceuticals across the world.
- You Are Leaving Lundbeck.com/US - Restore | HomeLundbeck is a biopharmaceutical company committed to researching, developing and delivering transformative therapies for brain diseases. We are tirelessly dedicated to restoring brain health so every person can be their best.
- FDA approves Lundbeck’s VYEPTI™ (eptinezumab-jjmr) - NewsRoomFDA approves Lundbeck’s VYEPTI™ (eptinezumab-jjmr) – the first and only intravenous preventive treatment for migraine. In two clinical studies (PROMISE-1 in episodic migraine and PROMISE-2 in chronic migraine), VYEPTI met its primary endpoint: decrease in mean monthly migraine days (MMD) over months1-3. A treatment benefit over placebo ...
- LundbeckAbout Us. With more than 70 years of neuroscience expertise, Lundbeck has developed and commercialized some of the world's most widely prescribed therapies for brain diseases. Our Science. LATEST NEWS. Lundbeck and Otsuka submit sNDA for FDA review of brexpiprazole and sertraline combination as potential treatment for PTSD.
More
